Revolution Total Debt To Capitalization from 2010 to 2024

RVMDW Stock   0.32  0.08  20.00%   
Revolution Medicines, Total Debt To Capitalization yearly trend continues to be fairly stable with very little volatility. Total Debt To Capitalization will likely drop to 0 in 2024. During the period from 2010 to 2024, Revolution Medicines, Total Debt To Capitalization regression line of quarterly data had mean square error of  0.0000033 and geometric mean of  0.01. View All Fundamentals
 
Total Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
0.00401895
Current Value
0.003818
Quarterly Volatility
0.00220442
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Revolution Medicines, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines,'s main balance sheet or income statement drivers, such as Net Interest Income of 49.5 M, Interest Income of 49.9 M or Interest Expense of 287.9 K, as well as many indicators such as Price To Sales Ratio of 294, Dividend Yield of 0.0 or PTB Ratio of 1.69. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines, Valuation or Volatility modules.
  
Check out the analysis of Revolution Medicines, Correlation against competitors.

Latest Revolution Medicines,'s Total Debt To Capitalization Growth Pattern

Below is the plot of the Total Debt To Capitalization of Revolution Medicines, Warrant over the last few years. It is Revolution Medicines,'s Total Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines,'s overall financial position and show how it may be relating to other accounts over time.
Total Debt To Capitalization10 Years Trend
Slightly volatile
   Total Debt To Capitalization   
       Timeline  

Revolution Total Debt To Capitalization Regression Statistics

Arithmetic Mean0.01
Geometric Mean0.01
Coefficient Of Variation23.60
Mean Deviation0
Median0.01
Standard Deviation0
Sample Variance0.00000486
Range0.0064
R-Value(0.61)
Mean Square Error0.0000033
R-Squared0.37
Significance0.02
Slope(0.0003)
Total Sum of Squares0.000068

Revolution Total Debt To Capitalization History

2024 0.003818
2023 0.004019
2022 0.009788

About Revolution Medicines, Financial Statements

Revolution Medicines, investors use historical fundamental indicators, such as Revolution Medicines,'s Total Debt To Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revolution Medicines,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.